Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7B |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$907M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$644M |
| 4 |
NVIDIA
NVDA
|
+$440M |
| 5 |
CRH
CRH
|
+$429M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$689M |
| 2 |
Home Depot
HD
|
+$377M |
| 3 |
Cigna
CI
|
+$322M |
| 4 |
Valero Energy
VLO
|
+$250M |
| 5 |
Amphenol
APH
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.35% |
| 2 | Technology | 9.23% |
| 3 | Healthcare | 7.6% |
| 4 | Financials | 5.15% |
| 5 | Consumer Discretionary | 5.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
Ranger Energy Services
RNGR
$387M
| $3.26M | ﹤0.01% |
230,090
+16,230
| +8% | +$189K |
|
3052
Xenon Pharmaceuticals
XENE
$5.81B
| $3.26M | ﹤0.01% |
95,493
-117,845
| -55% | -$4.41M |
|
3053
Trip.com Group
TCOM
$28.6B
| $3.26M | ﹤0.01% |
93,276
+59,077
| +173% | +$2.22M |
|
3054
Microvast
MVST
$278M
| $3.26M | ﹤0.01% |
1,722,984
-789,146
| -31% | -$1.69M |
|
|
VTNR
3055
DELISTED
Vertex Energy, Inc
VTNR
| $3.25M | ﹤0.01% |
730,958
-307,054
| -30% | -$1.58M |
|
3056
iShares Core MSCI EAFE ETF
IEFA
$195B
| $3.25M | ﹤0.01% |
50,460
-27,570
| -35% | -$1.85M |
|
3057
DuPont de Nemours
DD
$18.5B
| $3.23M | ﹤0.01% |
34,531
-51,695
| -60% | -$4.86M |
|
3058
Coupang
CPNG
$29.7B
| $3.23M | ﹤0.01% |
190,060
+87,647
| +86% | +$1.58M |
|
3059
CALL
ARK Innovation ETF
ARKK
$6.46B
| $3.23M | ﹤0.01% |
81,400
+50,000
| +159% | +$2.2M |
|
3060
Nomura Holdings
NMR
$30.1B
| $3.23M | ﹤0.01% |
803,059
+700,508
| +683% | +$2.79M |
|
3061
PUT
J.M. Smucker
SJM
$14.1B
| $3.22M | ﹤0.01% |
26,200
+16,400
| +167% | +$2.33M |
|
3062
Merchants Bancorp
MBIN
$2.45B
| $3.22M | ﹤0.01% |
116,138
+877
| +0.8% | +$25.3K |
|
3063
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$299M
| $3.22M | ﹤0.01% |
82,001
-28,000
| -25% | -$945K |
|
3064
Arbutus Biopharma
ABUS
$1B
| $3.21M | ﹤0.01% |
1,583,572
-118,610
| -7% | -$249K |
|
3065
PUT
Roku
ROKU
$23.4B
| $3.21M | ﹤0.01% |
45,500
+38,800
| +579% | +$3M |
|
3066
PUT
Bread Financial
BFH
$4.06B
| $3.21M | ﹤0.01% |
93,800
+400
| +0.4% | +$14.7K |
|
|
BBT
3067
Beacon Financial Corp
BBT
$2.63B
| $3.21M | ﹤0.01% |
159,942
+111,115
| +228% | +$2.38M |
|
3068
Capitol Federal Financial
CFFN
$1.07B
| $3.21M | ﹤0.01% |
672,165
+627,513
| +1,405% | +$3.71M |
|
|
PINC
3069
DELISTED
Premier
PINC
| $3.2M | ﹤0.01% |
148,870
-1,467,220
| -91% | -$36.6M |
|
3070
PUT
Match Group
MTCH
$9.54B
| $3.2M | ﹤0.01% |
+81,700
| New | +$3.62M |
|
3071
PUT
Corcept Therapeutics
CORT
$12.3B
| $3.2M | ﹤0.01% |
+117,400
| New | +$3.4M |
|
3072
Customers Bancorp
CUBI
$2.65B
| $3.19M | ﹤0.01% |
92,716
+36,980
| +66% | +$1.34M |
|
3073
PUT
Ralph Lauren
RL
$21.1B
| $3.19M | ﹤0.01% |
27,500
+7,700
| +39% | +$932K |
|
3074
PUT
Philips
PHG
$26.1B
| $3.19M | ﹤0.01% |
+178,871
| New | +$3.43M |
|
3075
DTE Energy
DTE
$28.3B
| $3.19M | ﹤0.01% |
32,117
-926,736
| -97% | -$99.7M |
|
Similar funds
Israel Englander's Q3 2023 Portfolio in Review
As of Q3 2023, Israel Englander held 6,895 positions worth $198B, down 2.3% from $203B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Israel Englander deployed $6.14B of net new capital in Q3 2023, opening 836 new positions and adding to 2,326 existing holdings. Its largest new stake was Mobileye: 2,953,164 shares worth $123M.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, down from 56% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $689M trimmed.
- Israel Englander's largest Q3 2023 buy was Mobileye: 2,953,164 shares worth $123M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $3.7B increase.
- Israel Englander's biggest Q3 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $689M.
- Israel Englander fully exited Blackstone in Q3 2023, selling an estimated $178M.
- Israel Englander's ten largest holdings make up 21% of its $198B portfolio in Q3 2023.
- Israel Englander opened 836 new positions and closed 834 in Q3 2023.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $198B.
Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.